Millipore Sigma Vibrant Logo

204869 Anti-Complement 3 Goat pAb

This Anti-Complement 3 Goat pAb is validated for use in Flow Cytometry, Immunoblotting, Immunocytochemistry, Immunoelectrophoresis for the detection of Complement 3.

Anti-Complement 3 Goat pAb : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
204869
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

Species ReactivityHostAntibody Type
Bab, Gp, Ht, Eq, H, M, Rb, RGtPolyclonal Antibody

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
204869-1ML
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 1 ml
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewMonospecific for C3 complement component. May also recognize C3 fragments, C3a, C3b, and C3c.
      Catalogue Number204869
      Brand Family Calbiochem®
      References
      ReferencesInal, J.M., et al. 2002. J. Immunol. 168, 5213.
      Williams, B.J., et al. 2001. Infect. Immun. 69, 695.
      Hindmarsh, E.J., et al. 1998. J. Immunol. 160, 6128.
      Product Information
      FormLiquid
      FormulationSerum diluted in 500 mM NaCl, 50 mM Tris-HCl, pH 7.5.
      Positive controlPurified C3 protein (Cat. No. 204885)
      Preservative≤0.1% sodium azide
      Quality LevelMQ100
      Applications
      Application ReferencesImmunoblotting Inal, J.M., et al. 2002. J. Immunol. 168, 5213. Williams, B.J., et al. 2001. Infect. Immun. 69, 695. Hindmarsh, E.J., et al. 1998. J. Immunol. 160, 6128. Flow Cytometry Williams, B.J., et al. 2001. Infect. Immun. 69, 695. Immunocytochemistry Hindmarsh, E.J., et al. 1998. J. Immunol. 160, 6128.
      Key Applications Flow Cytometry
      Immunoblotting (Western Blotting)
      Immunocytochemistry
      Immunoelectrophoresis
      Application NotesFlow Cytometry (see application references)
      Immunoblotting (see application references)
      Immunocytochemistry (see application references)
      Immunoelectrophoresis (use undiluted)
      Application CommentsMonospecific to human C3 complement component. This antibody has also been reported to recognize the C3 fragments, C3a, C3b, and C3c. Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogenpurified, human C3 complement component
      ImmunogenHuman
      HostGoat
      IsotypeIgG
      Species Reactivity
      • Baboon
      • Guinea Pig
      • Hamster
      • Horse
      • Human
      • Mouse
      • Rabbit
      • Rat
      Antibody TypePolyclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      204869-1ML 04055977219654

      Documentation

      Anti-Complement 3 Goat pAb FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Anti-Complement 3 Goat pAb Certificats d'analyse

      TitreNuméro de lot
      204869

      Références bibliographiques

      Aperçu de la référence bibliographique
      Inal, J.M., et al. 2002. J. Immunol. 168, 5213.
      Williams, B.J., et al. 2001. Infect. Immun. 69, 695.
      Hindmarsh, E.J., et al. 1998. J. Immunol. 160, 6128.

      Citations

      Titre
    • Jameel M. Inal and Jurg A. Schifferli. (2002) Complement C2 Receptor Inhibitor Trispanning and the β-Chain of C4 Share a Binding Site for Complement C21. Journal of Immunology 168, 5213-5221.
      		•
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision23-July-2007 RFH
      ApplicationFlow Cytometry (see application references)
      Immunoblotting (see application references)
      Immunocytochemistry (see application references)
      Immunoelectrophoresis (use undiluted)
      DescriptionGoat polyclonal antibody supplied as defibrinated, delipidized, and adsorbed (as needed) serum. Recognizes the C3 complement component.
      BackgroundThe complement system provides innate defense against microbial infection and is a "complement" to antibody mediated immunity. The complement system consists of thirty five interacting plasma and membrane associated proteins which contribute to host-defense and initiate and amplify inflammation, even in the preimmune state where specific antibodies and lymphocytes are not available. In addition to the complement components themselves, this system also contains several soluble factors that prevent spontaneous complement activation from occurring in solution, as well as, several regulatory membrane associated proteins that protect host cells from accidental complement attack. Cleavage of the C3 component by either the classical pathway or the alternative pathway releases C3a and C3b. C3a appears to be important in many inflammatory responses while the C3b fragment covalently binds to the cell or bacterial surface and plays a role in opsonisation. Binding of C3b to the C4b component of the C3 convertase, results in C5 convertase (C4b3b2a) formation.
      HostGoat
      Immunogen speciesHuman
      Immunogenpurified, human C3 complement component
      IsotypeIgG
      Speciesbaboon, not bovine, not canine, not chicken, not feline, guinea pig, hamster, horse, human, mouse, rabbit, rat, not sheep
      Positive controlPurified C3 protein (Cat. No. 204885)
      FormLiquid
      FormulationSerum diluted in 500 mM NaCl, 50 mM Tris-HCl, pH 7.5.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      CommentsMonospecific to human C3 complement component. This antibody has also been reported to recognize the C3 fragments, C3a, C3b, and C3c. Antibody should be titrated for optimal results in individual systems.
      Storage Avoid freeze/thaw
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
      Toxicity Standard Handling
      ReferencesInal, J.M., et al. 2002. J. Immunol. 168, 5213.
      Williams, B.J., et al. 2001. Infect. Immun. 69, 695.
      Hindmarsh, E.J., et al. 1998. J. Immunol. 160, 6128.
      Citation
    • Jameel M. Inal and Jurg A. Schifferli. (2002) Complement C2 Receptor Inhibitor Trispanning and the β-Chain of C4 Share a Binding Site for Complement C21. Journal of Immunology 168, 5213-5221.
      		•
      Application referencesImmunoblotting Inal, J.M., et al. 2002. J. Immunol. 168, 5213. Williams, B.J., et al. 2001. Infect. Immun. 69, 695. Hindmarsh, E.J., et al. 1998. J. Immunol. 160, 6128. Flow Cytometry Williams, B.J., et al. 2001. Infect. Immun. 69, 695. Immunocytochemistry Hindmarsh, E.J., et al. 1998. J. Immunol. 160, 6128.